Saudi Arabia - Re-Export of Antisera and Other Blood Fractions
Since 2014, Saudi Arabia Re-Export of Antisera and Other Blood Fractions fell by 25.7% year on year. At $60,585.57 in 2019, the country was ranked number 9 among other countries in Re-Export of Antisera and Other Blood Fractions. Saudi Arabia is overtaken by Moldova, which was ranked number 8 with $70,970 and is followed by Barbados at $52,226.9. United States topped the ranking with $614,613,635.05 in 2019, that is +5.9% compared to 2018. Italy, Canada and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. United Arab Emirates recorded the best 5 years average growth at +80.6% per year, while Oman recorded the worst performance at -61.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 60,585.57 |
| 2018 | 65,186.68 |
| 2017 | |
| 2016 | 95,744.84 |
| 2015 |
Download all data from 1991 to 2019
How does Saudi Arabia rank in Re-Export of Antisera and Other Blood Fractions?
| # | 16 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
614,613,635.05 | 2019 | +5.9 % | +3.9 % | View data | |
| 2 |
#2
Italy
|
509,690,540.30 | 2019 | +7.1 % | +21.3 % | View data | |
| 8 |
#8
Moldova
|
70,970.00 | 2019 | -13.5 % | -16.4 % | View data | |
| 9 |
#9
Saudi Arabia
|
60,585.57 | 2019 | -7.1 % | -25.7 % | View data | |
| 10 |
#10
Barbados
|
52,226.90 | 2019 | +17.6 % | +11.0 % | View data | |